Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
D Mar 1, 2023
DEF 14A Feb 24, 2023
S-3/A Feb 16, 2023
SC 13G/A Feb 14, 2023 AMENDMENT NO. 3
SC 13G/A Feb 14, 2023 SC 13G/A
PRE 14A Feb 13, 2023
8-A12G/A Feb 7, 2023
8-K Feb 7, 2023
SC 13G Feb 7, 2023 SC 13G
424B5 Feb 6, 2023
4 Feb 1, 2023
8-K Feb 1, 2023
8-A12G Feb 1, 2023
8-K Jan 31, 2023
S-3 Jan 31, 2023
8-K Jan 19, 2023
EFFECT Jan 17, 2023
CORRESP Jan 13, 2023
UPLOAD Jan 13, 2023
8-K Jan 13, 2023
S-3 Jan 9, 2023
424B4 Jan 3, 2023
EFFECT Dec 29, 2022
CORRESP Dec 27, 2022
UPLOAD Dec 23, 2022
← Newer Page 8 of 22 · 546 filings Older →